Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Descartes-08 in Dermatomyositis and Antisynthetase Syndrome
NCT07391605Phase 2Recruiting
- Sponsor
- Cartesian Therapeutics
- Start
- Apr 2026
- Primary completion
- Nov 2027
- Modality
- Gene Editing, Prophylactic Vaccines, Gene Silencing
- Countries
- 1
01
Overview
A Phase 2 trial of Descartes-08 in dermatomyositis (DM), antisynthetase syndrome (ASSD), sponsored by Cartesian Therapeutics. Started Apr 2026; status: recruiting.
02
Drugs
Descartes-08
03
Conditions
dermatomyositis (DM)antisynthetase syndrome (ASSD)
Beyond the preview
Go deeper on NCT07391605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07391605.